291 related articles for article (PubMed ID: 12861399)
1. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
2. Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinoma.
Kohya N; Miyazaki K; Matsukura S; Yakushiji H; Kitajima Y; Kitahara K; Fukuhara M; Nakabeppu Y; Sekiguchi M
Ann Surg Oncol; 2002 May; 9(4):371-9. PubMed ID: 11986189
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy.
Ma S; Egyházi S; Ringborg U; Hansson J
Oncol Rep; 2002; 9(5):1015-9. PubMed ID: 12168066
[TBL] [Abstract][Full Text] [Related]
4. [Expression of hMSH2 and hMLH1 in stomach cancer and their correlation with Helicobacter pylori infection].
Ma JM; Wang ZH; Liu M; Wang M; Zhang Y; Lu S; Liu LN; Xu GW
Ai Zheng; 2004 May; 23(5):535-9. PubMed ID: 15142449
[TBL] [Abstract][Full Text] [Related]
5. Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma.
Matsukura S; Miyazaki K; Yakushiji H; Ogawa A; Chen Y; Sekiguchi M
J Surg Oncol; 2003 Mar; 82(3):194-200. PubMed ID: 12619064
[TBL] [Abstract][Full Text] [Related]
6. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
Wright CL; Stewart ID
Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
[TBL] [Abstract][Full Text] [Related]
7. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
[TBL] [Abstract][Full Text] [Related]
9. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
[TBL] [Abstract][Full Text] [Related]
10. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
Oh K; Redston M; Odze RD
Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
[TBL] [Abstract][Full Text] [Related]
12. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer.
Murata H; Khattar NH; Gu L; Li GM
Cancer Lett; 2005 Jun; 223(1):143-50. PubMed ID: 15890247
[TBL] [Abstract][Full Text] [Related]
13. Effect of Helicobacter pylori infection on the expression of DNA mismatch repair protein.
Park DI; Park SH; Kim SH; Kim JW; Cho YK; Kim HJ; Sohn CI; Jeon WK; Kim BI; Cho EY; Kim EJ; Chae SW; Sohn JH; Sung IK; Sepulveda AR; Kim JJ
Helicobacter; 2005 Jun; 10(3):179-84. PubMed ID: 15904475
[TBL] [Abstract][Full Text] [Related]
14. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of hMLH1 and p53 immunohistochemical status in right-sided colon cancer.
Smyth EF; Sharma A; Sivarajasingham N; Hartley J; Monson JR; Cawkwell L
Dis Colon Rectum; 2004 Dec; 47(12):2086-91; discussion 2091-2. PubMed ID: 15657659
[TBL] [Abstract][Full Text] [Related]
16. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
17. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer.
Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC
Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455
[TBL] [Abstract][Full Text] [Related]
18. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
[TBL] [Abstract][Full Text] [Related]
19. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney JR; Field JK
Cancer Res; 2000 Aug; 60(15):4216-21. PubMed ID: 10945633
[TBL] [Abstract][Full Text] [Related]
20. Expression of the DNA mismatch repair proteins (hMLH1 and hMSH2) in infiltrating pancreatic cancer and its relation to some phenotypic features.
Tomaszewska R; Okoń K; Stachura J
Pol J Pathol; 2003; 54(1):31-7. PubMed ID: 12817878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
